On Wednesday 16th October 2024, Abbott Laboratories (NYSE: ABT) will release its highly anticipated third quarter financial results. This important announcement is scheduled to occur before market open.
the organization is poised to announce an estimated $1.20 profit per share for the quarter, as predicted by financial experts on Wall Street. Additionally, the firm is expected to reveal a total revenue of $10.55 billion for this period.
The experts on Wall Street have shared their predictions for how well the company will do this year. They think the total revenue will be around $41.75 billion. They also believe the company will reach about profit of $4.66 per share for the fiscal year.
The earnings report for the corresponding quarter in the previous year showcased a per-share income of $1.14. This considerable sum was attributed to the company's total revenue, which reached an impressive $10.14 billion during that specific quarter.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $1.14 | +5.6% | 10.38 B | +4.0% |
| Q1 2024 | $0.98 | -4.9% | 9.96 B | +2.2% |
| Q4 2023 | $1.19 | +15.5% | 10.24 B | +1.5% |
| Q3 2023 | $1.14 | -0.9% | 10.14 B | -2.6% |
| Q2 2023 | $1.08 | -24.5% | 9.98 B | -11.4% |
| *Growth on year-over-year basis | ||||
The business has scheduled a conference call on 16th October 2024 at 09:00 AM eastern time to discuss Q3 financial results.
Abbott Laboratories (ABT) closed Monday's regular trading session at $117.25, marking a 0.97 percent rise. The stock fluctuated between $115.98 and $117.58 during the day, with a volume of 3.67 million shares.
